Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its partsGottfrid Sjödahl, David M. Berman, Chelsea Jackson et al.|The Journal of Pathology|2019Cited by 89
Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancerChelsea Jackson, David M. Berman, R. J. Gooding et al.|The Journal of Pathology Clinical Research|2021Cited by 23
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy ClassifiersCéline Hardy, Chelsea Jackson, Hamid Ghaedi et al.|Journal of Histochemistry & Cytochemistry|2022Cited by 17
Abstract B10: A simple immunohistochemical algorithm to evaluate molecular subtypes and clinical associations in non-muscle invasive bladder cancerChelsea Jackson, David M. Berman, Lina Chen et al.|Clinical Cancer Research|2020Cited by 0
Abstract 616: Performance of IHC3-Uro immunohistechemistry-based molecular subtyping in muscle-invasive bladder cancerCéline Hardy, David M. Berman, Chelsea Jackson et al.|Clinical Research (Excluding Clinical Trials)|2021Cited by 0